ARCHIVES

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

This article is from The Cancer Letter archive.

Vol. 27 No. | August 3, 2001

Download PDF Visit The Full Archive

Related Articles

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Doxepin Rinse Reduces Pain In Radiation Therapy Patients

November 30, 2012

Justice Department Clears SWOG Study Of Breast Cancer Treatment Costs

November 17, 1995

No Site Visit For Georgetown Lombardi as Federal Government Shuts Down

October 4, 2013